Growth Metrics

Ionis Pharmaceuticals (IONS) Other Gross PP&E Adjustments (2010 - 2026)

Ionis Pharmaceuticals' quarterly Other Gross PP&E Adjustments came in at -$235.1 million in Q1 2026, down 47.59% year-on-year from -$448.5 million in Q1 2025, and down 8.49% quarter-over-quarter from -$216.7 million in Q4 2025.

Ionis Pharmaceuticals has reported Other Gross PP&E Adjustments for 17 years, with the latest figure at -$235.1 million in Q1 2026.

  • For the quarter ending Q1 2026, Other Gross PP&E Adjustments fell 47.59% year-over-year to -$235.1 million; the trailing twelve-month figure through Mar 2026 stood at -$235.1 million (down 47.59% YoY), and the FY2025 full-year result was -$216.7 million, down 312.57% from the prior year.
  • Other Gross PP&E Adjustments for Q1 2026 stood at -$235.1 million, down from -$216.7 million in the prior quarter.
  • The five-year high for Other Gross PP&E Adjustments was -$52.5 million in Q4 2024, with the low at -$242.0 million in Q3 2025.
  • Average Other Gross PP&E Adjustments over 5 years is -$176.0 million, with a median of -$171.9 million recorded in 2023.
  • Year-over-year, Other Gross PP&E Adjustments tumbled 510.94% in 2022 and surged 69.01% in 2024.
  • Tracing IONS's Other Gross PP&E Adjustments over 5 years: stood at -$194.2 million in 2022, then rose by 12.72% to -$169.5 million in 2023, then surged by 69.01% to -$52.5 million in 2024, then tumbled by 312.57% to -$216.7 million in 2025, then declined by 8.49% to -$235.1 million in 2026.
  • The last three Other Gross PP&E Adjustments figures came in at -$235.1 million (Q1 2026), -$216.7 million (Q4 2025), and -$242.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Gross PP&E Adjustments (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -83,048.00
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -60,691.22
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -285.20 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -892,000.00
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn -1.69 Bn
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn -189.30 Mn
10 Ionis Pharmaceuticals 12.61 Bn 10.69 Bn 243.11 Mn -235.06 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -235.06 Mn
Mar 31, 2026 -235.06 Mn
Dec 31, 2025 -216.68 Mn
Dec 31, 2025 -216.68 Mn
Sep 30, 2025 -241.99 Mn
Sep 30, 2025 -241.99 Mn
Jun 30, 2025 -163.93 Mn
Jun 30, 2025 -163.93 Mn
Mar 31, 2025 -159.27 Mn
Mar 31, 2025 -159.27 Mn
Dec 31, 2024 -52.52 Mn
Dec 31, 2024 -52.52 Mn
Sep 30, 2024 -164.42 Mn
Sep 30, 2024 -164.42 Mn
Jun 30, 2024 -166.94 Mn
Jun 30, 2024 -166.94 Mn
Mar 31, 2024 -169.43 Mn
Mar 31, 2024 -169.43 Mn
Dec 31, 2023 -169.48 Mn
Dec 31, 2023 -169.48 Mn
Sep 30, 2023 -174.31 Mn
Sep 30, 2023 -174.31 Mn
Jun 30, 2023 -176.72 Mn
Jun 30, 2023 -176.72 Mn
Mar 31, 2023 -179.15 Mn
Mar 31, 2023 -179.15 Mn
Dec 31, 2022 -194.18 Mn
Dec 31, 2022 -194.18 Mn
Dec 31, 2021 -31.78 Mn
Dec 31, 2021 -31.78 Mn
Dec 31, 2020 -11.07 Mn
Dec 31, 2020 -11.07 Mn
Dec 31, 2019 -4.74 Mn
Dec 31, 2019 -4.74 Mn
Dec 31, 2018 -7.53 Mn
Dec 31, 2018 -7.53 Mn
Dec 31, 2017 -33.93 Mn
Dec 31, 2017 -33.93 Mn
Dec 31, 2016 -6.47 Mn
Dec 31, 2016 -6.47 Mn
Dec 31, 2015 -20.90 Mn
Dec 31, 2015 -20.90 Mn
Dec 31, 2014 6.18 Mn
Dec 31, 2014 6.18 Mn
Dec 31, 2013 -10.20 Mn
Dec 31, 2013 -10.20 Mn
Dec 31, 2012 -10.20 Mn
Dec 31, 2012 -10.20 Mn
Dec 31, 2011 -10.78 Mn
Dec 31, 2011 -10.78 Mn
Dec 31, 2010 -705,000.00
Dec 31, 2010 -705,000.00